NIM
NVS icon

Northeast Investment Management’s Novartis NVS Stock Holding History

Northeast Investment Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.36M Sell
27,819
-1,073
-4% -$161K 0.16% 70
2026
Q1 		$4.41M Sell
28,892
-2,006
-6% -$307K 0.18% 66
2025
Q4 		$4.26M Sell
30,898
-72
-0.2% -$9.43K 0.17% 66
2025
Q3 		$3.97M Hold
30,970
– – 0.16% 67
2025
Q2 		$3.75M Sell
30,970
-66
-0.2% -$7.44K 0.16% 67
2025
Q1 		$3.46M Sell
31,036
-910
-3% -$96.9K 0.16% 68
2024
Q4 		$3.11M Sell
31,946
-152
-0.5% -$16.2K 0.14% 72
2024
Q3 		$3.69M Sell
32,098
-55
-0.2% -$6.24K 0.17% 71
2024
Q2 		$3.42M Buy
32,153
+6,223
+24% +$625K 0.16% 70
2024
Q1 		$2.51M Sell
25,930
-422
-2% -$43.3K 0.12% 75
2023
Q4 		$2.66M Sell
26,352
-675
-2% -$65.2K 0.14% 77
2023
Q3 		$2.75M Sell
27,027
-1,547
-5% -$157K 0.16% 76
2023
Q2 		$2.88M Buy
28,574
+54
+0.2% +$5.4K 0.16% 73
2023
Q1 		$2.62M Sell
28,520
-64
-0.2% -$5.59K 0.16% 75
2022
Q4 		$2.59M Sell
28,584
-891
-3% -$75K 0.17% 77
2022
Q3 		$2.24M Sell
29,475
-930
-3% -$77.1K 0.15% 77
2022
Q2 		$2.57M Sell
30,405
-390
-1% -$34.2K 0.16% 75
2022
Q1 		$2.7M Sell
30,795
-311
-1% -$26.9K 0.14% 76
2021
Q4 		$2.72M Sell
31,106
-6,906
-18% -$573K 0.13% 76
2021
Q3 		$3.11M Sell
38,012
-2,375
-6% -$214K 0.17% 77
2021
Q2 		$3.69M Sell
40,387
-1,975
-5% -$176K 0.2% 70
2021
Q1 		$3.62M Sell
42,362
-3,142
-7% -$282K 0.21% 67
2020
Q4 		$4.3M Sell
45,504
-3,013
-6% -$263K 0.26% 59
2020
Q3 		$4.22M Sell
48,517
-28
-0.1% -$2.43K 0.28% 62
2020
Q2 		$4.24M Buy
48,545
+2,565
+6% +$221K 0.32% 61
2020
Q1 		$3.79M Sell
45,980
-1,180
-3% -$105K 0.35% 62
2019
Q4 		$4.47M Sell
47,160
-412
-0.9% -$37K 0.33% 65
2019
Q3 		$4.13M Sell
47,572
-109
-0.2% -$9.79K 0.33% 66
2019
Q2 		$4.35M Sell
47,681
-5,530
-10% -$468K 0.35% 67
2019
Q1 		$4.58M Sell
53,211
-10
-0% -$803 0.39% 59
2018
Q4 		$4.09M Sell
53,221
-1,819
-3% -$142K 0.39% 58
2018
Q3 		$4.25M Sell
55,040
-11,091
-17% -$820K 0.34% 60
2018
Q2 		$4.48M Sell
66,131
-5,175
-7% -$357K 0.38% 61
2018
Q1 		$5.17M Buy
71,306
+544
+0.8% +$41.4K 0.46% 62
2017
Q4 		$5.32M Sell
70,762
-106
-0.1% -$8K 0.45% 63
2017
Q3 		$5.45M Sell
70,868
-391
-0.5% -$29.5K 0.48% 58
2017
Q2 		$5.33M Sell
71,259
-3,908
-5% -$277K 0.49% 57
2017
Q1 		$5M Sell
75,167
-23,187
-24% -$1.55M 0.47% 60
2016
Q4 		$6.42M Sell
98,354
-32,553
-25% -$2.11M 0.62% 54
2016
Q3 		$9.26M Sell
130,907
-25,391
-16% -$1.85M 0.93% 43
2016
Q2 		$11.6M Sell
156,298
-63,393
-29% -$4.38M 1.16% 36
2016
Q1 		$14.3M Sell
219,691
-20,036
-8% -$1.36M 1.47% 31
2015
Q4 		$18.5M Buy
239,727
+1,800
+0.8% +$143K 1.92% 17
2015
Q3 		$19.6M Sell
237,927
-2,821
-1% -$251K 2.12% 13
2015
Q2 		$21.2M Sell
240,748
-2,338
-1% -$214K 2.14% 12
2015
Q1 		$21.5M Sell
243,086
-4,586
-2% -$407K 2.11% 13
2014
Q4 		$20.6M Buy
247,672
+1,837
+0.7% +$152K 2.01% 15
2014
Q3 		$20.7M Buy
245,835
+3,634
+2% +$294K 2.08% 15
2014
Q2 		$19.6M Sell
242,201
-511
-0.2% -$40.2K 1.97% 19
2014
Q1 		$18.5M Sell
242,712
-2,670
-1% -$195K 1.97% 18
2013
Q4 		$17.7M Buy
245,382
+745
+0.3% +$51.8K 1.98% 16
2013
Q3 		$16.8M Buy
244,637
+3,720
+2% +$246K 2.04% 16
2013
Q2 		$15.3M Buy
+240,917
New +$15.7M 1.96% 17

Other funds holding NVS

SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GGI
Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Northeast Investment Management's NVS Position: Q2 2026 in Review

Northeast Investment Management reduced its Novartis (NVS) stake by 3.7% in Q2 2026, selling an estimated $161K and leaving 27,819 shares worth $4.36M. The position accounts for 0.16% of the portfolio, ranked #70.

Northeast Investment Management first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.5M in Q1 2015. 511 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Northeast Investment Management held 27,819 shares of Novartis worth $4.36M as of Q2 2026.
  • Northeast Investment Management sold 1,073 Novartis shares in Q2 2026, an estimated $161K.
  • Novartis made up 0.16% of Northeast Investment Management's portfolio in Q2 2026, its #70 holding.
  • Northeast Investment Management first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Northeast Investment Management's Novartis position peaked at $21.5M in Q1 2015.
  • 511 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.